Why the study?
What are the optimal stepwise strategies, tools, and anticoagulation thresholds for screening asymptomatic or high-risk individuals for atrial fibrillation according to the EHRA consensus document?
What are the optimal stepwise strategies, tools, and anticoagulation thresholds for screening asymptomatic or high-risk individuals for atrial fibrillation according to the EHRA consensus document?
This review of the EHRA consensus document outlines a pragmatic, stepwise approach to targeted AF screening (opportunistic in ≥65 years, systematic in ≥75 years or high stroke risk) while highlighting critical evidence gaps regarding oral anticoagulation for brief device-detected subclinical AF episodes.
Answers are grounded in this paper and cite their sources.
Supports stepwise opportunistic AF screening in older adults; leaves anticoagulation thresholds for device-detected episodes unresolved.
In this paper, we reviewed the atrial fibrillation screening strategies in a stepwise manner and discussed the uncertainties in the assessment of the need for anticoagulation in light of the recently published European Heart Rhythm Association consensus document. We reviewed not only the methods and tools but also the role of health care professionals and patient organizations in addition to cost-effectiveness issues.
No takes yet. Share an insight, caveat, or question.
Emin Evren Özcan (2018) conducted a review in Atrial fibrillation (asymptomatic or subclinical). Stepwise atrial fibrillation screening (pulse palpation, automated BP monitors, handheld/patch ECGs, CIED interrogation) vs. No screening or systematic vs. opportunistic screening was evaluated on Atrial fibrillation detection and thromboembolic event prevention.
Synapse has enriched 10 related papers. Consider them for comparative context: